Sort
326,823 grants matching “clinical trial”
The Alliance NCTN Biorepository and Biospecimen Resource
$3,958,268Mark A Watson · Washington University · U24 · FY2023 · CA
Myeloproliferative Neoplasms-Research Consortium
$3,957,858Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Disease Status Drug Metabolism and New Drug Discovery
$3,957,647Irving William Wainer · National Institute On Aging · ZIA · FY2014 · AG
Development of direct-acting flavivirus inhibitors
$3,957,517Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Examination Of Natural History And Therapy Of Multiple Sclerosis Using MRI
$3,957,485Henry F McFarland · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Development of SBS-226, a MOR agonist / DOR antagonist, for OUD
$3,957,359Jeffrey Reich · Sparian Biosciences, Inc. · UG3 · FY2024 · DA
The Ohio State University Comprehensive Cancer Center
$3,956,712Michael A Caligiuri · Ohio State University · P30 · FY2009 · CA
University of Arizona - Banner Health Precision Medicine Initiative Cohort Enrollment Center
$3,956,243Akinlolu O Ojo · University Of Arizona · UG3 · FY2016 · OD
DATA AND STATISTICS CENTER FOR THE NIDA CLINICAL TRIALS NETWORK
$3,956,081Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2012 · DA
Chronic Lymphocytic Leukemia Research Consortium
$3,956,000Thomas J. Kipps · University Of California, San Diego · P01 · FY2006 · CA
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$3,954,316Judith S. Currier · University Of California Los Angeles · UM1 · FY2024 · AI
GCC Genomic Characterization Centers
$3,953,948David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Project 2: mRNA vaccine development against Bunyaviruses, Paramyxoviruses and Picornaviruses
$3,953,703Norbert Pardi · University Of California-Irvine · U19 · FY2024 · AI
HIV Preventive Vaccine Studies
$3,952,801Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$3,952,086Robert Stanley Sherwin · Yale University · UL1 · FY2008 · RR
CTSA UM1 Program at Wake Forest
$3,951,899Thomas K Houston · Wake Forest University Health Sciences · UM1 · FY2025 · TR
MALARIA VACCINE EVALUATION
$3,951,837Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
Cancer Center Support Grant
$3,950,935Benjamin G. Neel · New York University School Of Medicine · P30 · FY2020 · CA
Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium
$3,950,734Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2022 · DK
NIAID Specimen Repository
$3,950,284Deborah Phippard · Precision Bioservices, Inc. · N01 · FY2022 · AI
Development of (R,R)-dehydronorketamine for treatment resistant depression
$3,950,053Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Drug Development Support for the CTEP
$3,949,326Melynda Holmes · Technical Resources International, Inc. · N02 · FY2010 · CA
Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study
$3,948,054Harold I Feldman · University Of Pennsylvania · U01 · FY2008 · DK
Statistics Core
$3,946,546Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2022 · CA
FOR-DMD:Double-blind randomized trial to optimize steroid regimen in Duchenne MD
$3,946,196Robert C Griggs · University Of Rochester · U01 · FY2010 · NS